SCHEMBL4102165

SCHEMBL4102165

O=S(=O)(c1ccccc1)N1CCCN(Cc2cc(Cl)ccc2O)CC1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 4/20 0.70
KDM4E B2RXH2 4/20 0.59
ALDH1A1 P00352 4/20 0.59
SMN1; SMN2 Q16637 3/20 0.54
MAPT P10636 2/20 0.54
GAA P10253 2/20 0.54
HTT P42858 2/20 0.54
TDP1 Q9NUW8 2/20 0.54
MITF O75030 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
THRB P10828 1/20 0.54
TSHR P16473 2/20 0.52
LMNA P02545 2/20 0.52
PKM P14618 1/20 0.52
TRPV4 Q9HBA0 1/20 0.51
TP53 P04637 1/20 0.50
RECQL P46063 1/20 0.50
MEN1 O00255 1/20 0.49
ALOX15 P16050 1/20 0.49
MAPK1 P28482 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27713019 0.95 PTGDR2 (0.67) PTGDR2KDM4EALDH1A1SMN1; SMN2MAPT
SCHEMBL1714590 0.87 PTGDR2 (0.68) PTGDR2KDM4EALDH1A1SMN1; SMN2MAPT
SCHEMBL1714387 0.82 PTGDR2 (1.00) PTGDR2KDM4EALDH1A1TP53
SCHEMBL9975978 0.80 KDM4E (0.65) KDM4EALDH1A1MAPTGAAHTT
SCHEMBL27712891 0.78 PTGDR2 (0.73) PTGDR2KDM4EALDH1A1SMN1; SMN2TSHR
SCHEMBL28770778 0.78 PTGDR2 (0.69) PTGDR2KDM4EALDH1A1MAPTGAA
SCHEMBL1714744 0.78 LMNA (0.81) KDM4EALDH1A1MAPTGAAHTT
SCHEMBL27712886 0.77 PTGDR2 (0.71) PTGDR2SMN1; SMN2L3MBTL1TSHRMEN1
SCHEMBL27693139 0.77 PTGDR2 (0.71) PTGDR2SMN1; SMN2L3MBTL1TSHRMEN1
SCHEMBL13800181 0.77 PTGDR2 (1.00) PTGDR2KDM4EALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8524715-B2 Phenoxyacetic acid derivatives useful for treating respiratory diseases ASTRAZENECA AB (SE) 2013-09-03 US disclosed
US-20090149448-A1 Phenoxyacetic Acid Derivatives Useful for Treating Respiratory Diseases ASTRAZENECA AB (SE) 2009-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090149448-A1 Phenoxyacetic Acid Derivatives Useful for Treating Respiratory Diseases PAOX, PCCA, PAH PTGDR2 236/4885KDM4E 1277/4885ALDH1A1 288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.